An ultrastructural study on the effect of streptozotocin on the islets of Langerhans in mice

Journal of Electron Microscopy

Volumn 49, Issue 5, 2000, Pages 681-690

  Aughsteen, A A ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Islets of Langerhans; Mice; Streptozotocin; Ultrastructural changes

Indexed keywords

CELL MEMBRANES; CELL PROLIFERATION; ELECTRON MICROSCOPES; MAMMALS; MORPHOLOGY;

AFTER-TREATMENT; B CELLS; BODY WEIGHT; INTRAVENOUS INJECTIONS; ISLETS OF LANGERHANS; MOUSE; STREPTOZOTOCIN; TIME INTERVAL; ULTRASTRUCTURAL CHANGES; ULTRASTRUCTURAL STUDY;

CELL DEATH;

EID: 0033765720     PISSN: 00220744     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jmicro.a023859     Document Type: Article

References (35)

1. Streptozotocin: A review of its pharmacology, efficacy, and activity
2. Streptozotocin-induced diabetes and islet cell alterations in rabbits
3. Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies
4. Mechanisms of streptozotocin and alloxan induced damage in rat B cells
5. Responses of pacreatic B cells to alloxan and streptozotocin in the guinea pig
6. Blood glucose and pancreatic islets in frogs after streptozotocin treatment
7. Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin
8. Antitumor and hyperglycemic activity of streptozotocin (NSC-37917) and its cofactor U-15,774
9. Studies of the diabetogenic action of streptozotocin
10. Streptozotocin diabetes in the mouse and guinea pig
11. Changes in somatostatin concentration in pancreas and other tissues of streptozotocin diabetic rats
12. Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic B cell cytotoxicity
13. Regulation of proinsulin synthesis in pancreatic islets and new aspect to insulin-dependent diabetes
14. Survival and B-cell function of mouse pancreatic islets maintained in culture after concomitant exposure to streptozotocin and nicotinamide
15. Effects of nicotinamide on prevention and treatment of streptozotocin-induced diabetes mellitus in rats
16. Ultrastructural aspect of streptozotocin cytotoxicity on rat pancreatic islets in vitro. Test of a protective effect of zinc
17. Effect of diabetes on islet area and B-cell function
18. Decrease in insulin-containing secretory granules and mitochondrial gene expression in mouse pancreatic islets maintained in culture following streptozotocin exposure
19. Morphometric studies on the juxta-insular and tele-insular acinar cells of the pancreas in normal and streptozotocin-induced diabetes rats
20. Correlative morphometric and biochemical study on pancreatic amylase in normal and streptozotocin-diabetic rats
21. Essential contribution of macrophages to islet cell destruction in vivo and in vitro
22. Macrophage-specific chemotactic lipid release by in vivo streptozotocin-administrated mouse islets
23. Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings
24. Specific immunity to streptozotocin. Cellular requirements for induction of lymphoproliferation
25. Ultrastructural observation on cytotoxic effector cells infiltrating pancreatic islets of low-dose streptozocin treated mice
26. 3H-leucin uptake of peri- and tele-insular acinar cells of the pancreas in normal and streptozotocin-diabetic mice
27. Streptozotocin at low doses induced apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1
28. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model
29. DNA strand breaks and poly (ADP-ribose) synthetase activation in pancreatic islets - A new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors
30. Protective effect of gamma-hydroxybutyrate and nicotinamide on low-dose streptozotocin-induced diabetes in mice
31. Molecular mechanisms of beta cell destruction in IDDM: The role of nicotinamide
32. Nicotinamide protects human beta cells against chemically-induced necrosis, but not against cytokin induced apoptosis
33. Mice lacking the poly (ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozotocin
34. Poly (ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes